Migraine Prevention vs Abort: Can a Daily Microdose Change Frequency?

Curtains still shut at three. Phone face-down. You already counted this as day four this month.

People talk about cannabis like it's one move. It's two jobs. One is abort: stop an attack that already started. The other is prevention: change how often the month fills up. This page stays on that split. The broader migraine map lives in our cannabis for migraines guide.

A daily cannabis microdose hasn't been proven to cut migraine frequency. Chart reviews and registries show some people logging fewer headache days on regular cannabis, but that's a different animal than a trial proving a tiny daily dose works. The cleanest modern trial we have is for abort, not a daily schedule. Keep your CGRP shot, your topiramate, and your triptan talk with the clinician who already knows your month.

Divine Toke is a Detroit-area Michigan shop. We grow sun-grown flower and sell jars, 1g pre-rolls, and a 20-pack of those 1g joints. No edibles on our shelf. No milligram protocol from this farm.

Can a Daily Cannabis Microdose Reduce How Often Migraines Show Up? #

Maybe for some people, and only as a weak signal. No randomized trial has shown that a tiny daily cannabis dose cuts monthly migraine days. The hope comes from older clinic charts and newer registries. The proof bar for a real preventive (fewer migraine days across a month) is still empty for microdosing.

The 2026 split:

Job	What you are trying to change	Best cannabis evidence as of 2026	What it isn't
Prevention	How often attacks show up (monthly migraine days)	Observational. Rhyne 2016 saw 10.4 to 4.6 headache days a month in 121 Colorado clinic charts.	Not a proven daily microdose protocol.
Abort	Pain and other symptoms once an attack has started	One placebo-controlled crossover trial of vaporized flower (Schuster, Headache 2026, PMC12872409)	Not a study of daily use or of next month's count.

"Microdose" in everyday talk usually means a small THC amount that doesn't wreck the afternoon. Our microdosing guide uses that 1 to 5 mg range for function, not for migraine prevention. The migraine papers did not test that range as a named protocol.

Why people still ask: some researchers think migraine sits next to a low endocannabinoid tone. Ethan Russo laid that out as clinical endocannabinoid deficiency in PMC5576607. A daily pinch of plant cannabinoids might keep that thermostat from running cold. Might is the word. The short version lives in endocannabinoid deficiency.

What the papers actually support:

• Regular cannabis users in clinic charts often logged fewer headache days.
• Those charts can't prove the plant caused the drop.
• A tiny daily dose has not been isolated as the thing that did it.
• Aborting an attack and changing frequency are different questions.

Daily weed is a frequency experiment you and your clinician watch. Nobody published it as a prevention drug.

Who this page is for:

• Adults who already live with migraine and already have a pill drawer.
• People in Detroit and across Michigan who keep hearing "just microdose every day."
• Anyone mixing up a joint that helps this attack with a plan that changes next month.

Who should stop and call a licensed person instead of finishing a farm blog:

• Headache on 15 or more days a month already.
• You are pregnant, trying, or chestfeeding.
• A job that drug-tests (CDL, plant, hospital badge).
• A new "worst headache of my life," one-sided weakness, or fever. That's emergency care, not flower.

What "Reduce Frequency" Has to Mean #

It means fewer migraine days on a calendar, not "I felt nicer on Tuesday." Headache trials count monthly migraine days. A good week after a bad week isn't prevention. Weather, sleep, hormones, and the pill you already take all move the same number.

Metro Detroit makes that messy. A 2 a.m. plant shift, a hospital night, or a winter week with no sun can stack triggers on top of whatever you smoked. You can't read one calm Saturday as proof the daily pinch is working.

What Is the Difference Between Prevention and Abort? #

Prevention tries to change how often attacks show up. Abort tries to stop one attack that already started. Same head. Two clocks. Mixing them up is how people swallow a daily pinch and then get mad it didn't kill the aura that started at lunch.

Plain words:

• Prevention / prophylaxis: you take something on a schedule (daily pill, monthly shot) so the next month has fewer migraine days.
• Abort / acute treatment: you take something when the attack starts so pain, light, and nausea back off in hours, not days.

The American Headache Society 2024 position statement puts CGRP-targeting therapies on the first-line prevention list. Topiramate, propranolol, amitriptyline, and related older preventives stay on that map too. Cannabis is not on that list. Societies list drugs when the evidence is thick enough. This plant isn't there yet.

	Prevention	Abort
Clock	Weeks and months	Minutes to hours
Win	Fewer migraine days	This attack lets go
Clinic examples	CGRP antibodies, gepants used on a schedule, topiramate, propranolol	Triptans, some gepants, NSAIDs
Cannabis evidence	Charts and registries	One vaporized-flower RCT
Risk if you overdo it	Tolerance, daily impairment, possible rebound pattern	Using abortives so often the month becomes a headache

A triptan that works in two hours is an abort. A CGRP shot that cuts your month from 12 days to 6 is prevention. A joint you light because the kitchen light already hurts is abort. A tiny evening pinch you take "so this month is quieter" is you trying prevention. Trying still needs proof.

Inhaled flower hits blood fast. That's why people reach for it when the attack is already on. A slow edible sits around longer. Divine Toke doesn't sell edibles, so that second lane is another brand. Fast onset helps abort. Long, even exposure is the theory behind a daily pinch. That theory still needs a trial.

If your neurologist already split your cabinet into "every day" and "when it hits," keep that split.

Where cannabis sits next to real preventives #

It sits off to the side, as an unproven extra, not as a peer of a CGRP antibody. The 2024 AHS update says CGRP-targeting therapies are a first-line prevention option and shouldn't require you to fail older pills first. Topiramate, propranolol, amitriptyline, and related drugs remain on the board. Cannabis doesn't.

If your shot already cut the month, a daily pinch is a side question. If nothing has cut the month, the next evidence-based move is still a clinician, not a bigger jar.

Some people will still add flower because the shot is expensive, the pill fog is ugly, or the prior auth died. Fine. Name it as add-on watching. Don't name it as a replacement you read on a farm site.

What Does the Frequency Evidence Actually Show? #

Clinic charts and one 2026 registry show fewer headache days and better quality-of-life scores in people who already used medical cannabis. Those designs can't prove a daily microdose caused the drop. If someone quotes "half the migraines" at you, this is the paper they mean, and this is what it can and can't carry.

The Colorado chart review everyone cites #

Rhyne and colleagues (2016, PMID 26749285) pulled charts from two Colorado medical-cannabis clinics. They found 121 adults with a primary migraine diagnosis, a physician note that cannabis was for migraine treatment or prevention, and at least one follow-up visit.

What they logged:

• Headache frequency fell from 10.4 to 4.6 headaches a month (p < 0.0001). 103 of 121 (85.1%) charts showed a measured drop. Fifteen stayed the same. Three went up.
• Most people used more than one form and used it daily for prevention.
• 48 of 121 (39.7%) reported a positive effect.
• 24 of 121 (19.8%) is the self-reported “prevention / fewer attacks” box, not the calendar primary.
• 14 of 121 (11.6%) said an attack aborted.
• Inhaled cannabis was the common abort move.
• 14 of 121 (11.6%) reported a negative effect. Edibles showed more timing and intensity problems.

The same chart pile already split the two jobs: daily use for prevention, inhale to abort. The authors still said prospective studies were needed for cause and effect. They were right. People who stay in a clinic chart aren't the same as people who tried it, felt worse, and never came back.

The 2022 narrative review of 12 papers #

Okusanya et al. (2022, PMC9197380) is a narrative review of 12 publications and 1,980 people in Italy and the United States, not a pooled meta-analysis. They wrote that medical cannabis reduced migraine days after 30 days, reduced monthly frequency, and was 51% more effective than non-cannabis products in the papers they had. They also flagged medication-overuse headache and called for real experimental trials.

Treat "51%" as a review headline, not a promise for your September. Those 12 papers weren't one clean daily-microdose study.

The 2026 UK registry #

Hooper et al. (Brain and Behavior 2026, PMC13053313) followed 203 adults in the UK Medical Cannabis Registry. Headache-impact, anxiety, sleep, and quality-of-life scores looked better out to 24 months. A migraine-disability score looked better out to 12 months. Median THC rose from 19 to 134 mg/day. Median CBD rose from 20 to 25.5 mg/day. 31 of 203 people (15.27%) reported adverse events, including 3 life-threatening or disabling ones: somnolence (heavy sleepiness), delirium, and confusion. The authors said randomized trials are required to establish causation. Several authors work at the clinic that supplied the products. The numbers can still be real. This is a clinic registry with authors on the payroll.

Source	Design	n	Frequency signal	Caveat
Rhyne 2016	Retrospective charts	121	10.4 to 4.6 headache days / month; 103/121 measured drop	No control group. Daily mix of forms.
Okusanya 2022	Narrative review	1,980 across 12 papers	Days and frequency down; "51%" vs non-cannabis products	Not a pooled meta-analysis. Asks for trials.
Hooper 2026	Observational registry	203	Better HIT-6 and related scores	Median THC 19 → 134 mg/day. 3 severe AEs. Not an RCT. Clinic conflicts disclosed.

None of these tested "1 to 2.5 mg THC every night" as a named arm. Daily use showed up. Microdose-as-protocol didn't.

Why a big drop in a chart can still be a lie #

People often enter a cannabis clinic on a bad stretch. Bad stretches ease. That's called regression to the mean, and it looks like a miracle. Add self-selection: the person who felt worse never came back, so they never entered the "it worked" pile. Add other changes: a new preventive, fewer work nights, a different abort pill.

That's why Rhyne asked for prospective studies, and why Hooper asked for randomized trials. A 10.4 to 4.6 drop is worth knowing. Leave your CGRP shot alone until the clinician says otherwise.

If a budtender says "half your migraines," ask what design they mean. Chart, registry, or RCT. Only one of those can pin cause. We don't have that one for daily microdose prevention.

Why Is Abortive Evidence Stronger Than Preventive Evidence? #

Because abort has a placebo-controlled crossover trial, and prevention doesn't. Schuster and colleagues vaporized cannabis flower against placebo flower for acute migraine. They enrolled 92 adults and treated 247 attacks. The trial is on ClinicalTrials.gov as NCT04360044. The published Headache paper (2026, PMID 41469488) is the one to cite, not a blog recap.

What they actually dosed: four puffs of National Institute on Drug Abuse flower.

• 6% THC + 11% CBD
• 6% THC (THC-dominant)
• 11% CBD (CBD-dominant)
• Placebo flower with the THC and CBD pulled out

The flower had almost no minor cannabinoids and no terpenes. That's NIDA lab flower, not a living-soil jar from a Michigan farm. Good for a clean test. Your tray is a different soup.

Two-hour results for the THC+CBD arm versus placebo:

• Pain relief: 67.2% vs 46.6%
• Pain freedom: 34.5% vs 15.5%
• Most-bothersome-symptom freedom: 60.3% vs 34.5%

THC-dominant beat placebo on pain relief (68.9% vs 46.6%) but not on pain freedom or the most-bothersome symptom. CBD-dominant did not beat placebo on those abort endpoints. No serious adverse events.

The authors said it in plain language: the study didn't examine the long-term effects of frequent use. They left prevention off the table on purpose.

Arm	Abort win at 2 hours?	Says anything about next month's count?
6% THC + 11% CBD	Yes vs placebo	No
6% THC	Pain relief only	No
11% CBD	No	No
Placebo flower	Baseline	No

So if a friend says "the science says weed stops migraines," they are usually pointing at this abort trial. If they say "so take a tiny bit every day and you will get fewer of them," they have left the paper. The same research group is telling you they didn't study that.

Fast inhale is why abort looks plausible. Lungs to blood in minutes. That matches "the light just went sharp." A daily pinch is a different bet: keep the system a little less twitchy. The migraines pillar covers how THC and CBD sit on that system. This page only needs the clock: hours versus months.

Who was allowed into the abort trial #

The abort paper was picky, and that matters if you are trying to copy it at home. Schuster 2026 enrolled adults 21 to 65 with migraine by ICHD-3 rules, and 2 to 23 headache days and migraine days a month. People agreed not to use outside cannabis, opioids, or barbiturates during the study. A positive THC urine test at screening was an exclusion. Active lung disease was out. So was current moderate-to-severe depression, and a history of bipolar disorder, schizophrenia, or psychosis.

They also used flower without terpenes. Your Michigan sun-grown jar is a different chemical soup. That can be good for smell and for the night. It means you can't say "I matched the study" because you took four puffs of whatever is on the tray.

The trial treated an attack within the first four hours of onset. That's abort timing. Yesterday's 9 p.m. pinch sits on a different clock.

Does Daily Cannabis Raise Rebound Headache Risk? #

It might be in the same neighborhood as other overused abortives, but the proof is an association, not a society rule that names cannabis like it names triptans. Daily plant use isn't "safer than pills" just because it grew outside.

ICHD-3 medication-overuse headache is headache on 15 or more days a month in someone who already had a headache disorder, plus regular overuse of an acute medicine for more than 3 months. Triptan-overuse headache uses a tighter count: 10 or more triptan days a month for more than 3 months.

Zhang and Woldeamanuel (2021, PMID 34370866) looked at 368 adults with chronic migraine at Stanford headache clinics. Medication-overuse headache showed up in 81% of current cannabis users (122 of 150) versus 41% of people not using cannabis (90 of 218). The adjusted odds ratio was 6.3. Cannabis use also lined up with opioid use. The authors said advising people with chronic migraine and overuse to cut cannabis may help treat the overuse pattern.

Treat it as a red flag. The study is charts. Nobody got randomly assigned. People with worse months may be the ones who already smoke more. Still: if your month is already 15-plus headache days, adding a daily pinch isn't a free move.

Okusanya 2022 also tied medical cannabis for migraine to medication-overuse headache in the papers they reviewed. Same caution, same missing trial.

What you are counting	Line the classification uses	Why it matters on a daily-cannabis month
Headache days	≥15 / month for MOH	If the month is already that full, daily anything abort-like needs a clinician
Triptan days	≥10 / month for triptan-overuse	Don't stack a daily plant on top of a hot triptan count and call it "natural prevention"
Cannabis days	No ICHD subtype that names cannabis	Association in Zhang 2021, not a formal class rule

Nobody here is telling you to drop your triptan. Count the days on the same calendar. If the abort pill and the evening pinch are both happening 12, 15, 20 days a month, the month can get louder. That's the rebound story people already know from painkillers. Cannabis doesn't get a special pass just because the jar smells like a farm.

Stacking a daily pinch on top of abort days #

A nightly "prevention" pinch plus a daytime abort inhale can become one long use pattern. That's the quiet way a frequency experiment turns into the thing Zhang 2021 was worried about.

If the daily pinch is truly small and you still abort 12 days a month, you don't have prevention. You have two cannabis days stacked on a loud month. Log them separately. If the abort count doesn't fall when the daily pinch starts, the daily pinch isn't doing the job on the label you gave it.

People with chronic migraine already sit closer to the 15-day line. They are the group in the Stanford charts. They are also the group most tempted by "maybe a little every night will keep it off." That's the group that needs the clinician in the room first, not last.

How Does a Consumer Microdose Compare to the Doses in the Papers? #

The word "microdose" on a porch and the doses in migraine papers aren't the same thing. Don't copy a trial puff count into a bedtime habit and call it science.

Everyday microdose talk (small THC, still functional) lives in our microdosing guide. That page is about staying useful.

What the migraine papers actually used:

• Rhyne 2016: "daily" prevention, mixed smoked, edible, and other forms, no locked milligram.
• Schuster 2026: four puffs of ~6% THC / ~11% CBD flower, once per treated attack, not every night. Washout of at least a week between treated attacks.
• Hooper 2026: clinic cannabis-based products at median THC 19 → 134 mg/day and CBD 20 → 25.5 mg/day. Higher THC lined up with a better disability score, with wide confidence intervals. That's not a 2 mg endorsement.

Two unpublished prevention protocols sit on ClinicalTrials.gov: NCT03972124 (CBD 100/200 mg once a day) and NCT04989413 (CBD 133 / CBG 66 / THC 4 mg daily max). Both have no published efficacy. Neither is a how-to.

Label people use	What it usually means	In the migraine papers?
Consumer microdose	About 1 to 5 mg THC, stay functional	Not tested as a named migraine-prevention arm
Daily medical cannabis	Regular use, often mixed forms	Yes, in Rhyne charts
Abort inhale	A few puffs when the attack starts	Yes, Schuster RCT
"Just match the study"	Four puffs of 6/11 flower every night	The study didn't do that

Tolerance still exists. Daily THC can dull the same receptors you hope are helping. Older "microdosing prevents tolerance" talk doesn't hold as a 2026 consensus. Lower and less often may slow the fade. It doesn't cancel it. If the tiny evening pinch stops doing anything by week six, write it down.

If you take a triptan, a CGRP shot, an antidepressant, or blood-pressure medicine, read cannabis and medication interactions before you stack a daily pinch. "Natural" doesn't mean invisible to the liver.

There is no start-here milligram for migraine prevention. Not in the papers, and not from this farm. If you and your clinician decide to try a small daily amount anyway, treat it as a watch, not a prescription you pulled from a farm blog.

How Do You Track Whether Frequency Actually Changed? #

Count migraine days for two or three full months, on the same calendar you already use for pills. One quiet week after a bad week is weather, sleep, or luck. It isn't prevention.

Headache clinics already live on monthly migraine days. You can steal that without buying a new app. A day counts if migraine showed up, even if you worked through it. Abort days (triptan, inhale, dark room) get their own tally. Prevention only shows up if the migraine-day number moves.

Minimum log, same notebook every night:

1. Did a migraine show up today? Yes or no.
2. What abort did you use (triptan, NSAID, inhale, nothing)?
3. Did you take the daily pinch? Yes or no.
4. Sleep hours, shift, period, weather if you already track those.
5. Impairment: note if you could drive, parent, or stand a job site.

Our cannabis journaling guide is the longer version of that notebook. Use it. Don't trust memory after a fluorescent grocery run.

After 8 to 12 weeks	Read it this way
Migraine days clearly down, abort days down, you can still work	Possible frequency help. Stay with the clinician.
Migraine days flat, but abort inhale works faster	You may have an abort tool, not a preventive.
Migraine days up, or 15-plus headache days	Stop guessing. That's a rebound / chronification talk, not a bigger joint.
You need more plant to feel the same	Tolerance. Daily isn't free.

Metro Detroit winters will lie to you. A dark January and a 12-hour hospital stretch can add days that have nothing to do with the jar. Mark those weeks. Compare like to like: two day-shift months, not July vacation versus February overtime.

If you can't tell after three honest months, the daily pinch didn't earn a permanent spot. That's a clean result. You can let the daily pinch go.

A simple month box you can copy:

Week	Migraine days	Triptan days	Cannabis abort days	Daily pinch days	Notes (shift, weather, period)
1
2
3
4
Month total

Four numbers. That's enough. If cannabis abort days climb while migraine days stay flat, you aren't preventing. You are treating more attacks with the plant.

What Should Michigan Shoppers Know Before Adding a Daily Low Dose? #

Migraine isn't a named qualifying condition on the Michigan medical-card list. Chronic pain is. Adults 21 and older can still buy adult-use flower without a card, inside state possession limits. The plant doesn't become a preventive because you bought it in Detroit.

The CRA eligible-conditions page names chronic pain. It also names severe and chronic pain as a symptom of another chronic disease or its treatment. It does not name migraine or headache. A Michigan physician can still certify you if your case fits a named lane. That's a clinic call. Card steps sit on the MMMP page.

Adult-use is the other door. MCL 333.27955 lets a person 21 or older possess 2.5 ounces or less, with no more than 15 grams of that as concentrate. The CRA adult-use summary of MRTMA matches that picture. A daily pinch of flower fits inside that cap. It doesn't create a special medical right at work. Plant jobs, CDLs, and hospital badges still test.

Buy from a licensed shop under the Michigan Cannabis Regulatory Agency. Read the label. Ask for the COA. Gas-station delta-8 isn't this conversation.

Divine Toke is Detroit-rooted and Michigan-grown. We sell sun-grown organic flower, 1g pre-rolls, and a 20-pack of 20 × 1g joints. That's the shop. There is no Divine Toke gummy, no "migraine tincture," no half-gram listing. A 1g joint is a known size if you are trying to keep a day small. A 20-pack is for people who already know the jar, not a dare to smoke 20 abort days in a row.

Michigan fact	Why it matters on a daily-dose month
Migraine not named on the CRA list	Don't walk into a clinic quoting this page as a card ticket
Chronic pain is named	Some people reach a card through that lane. Physician decides.
2.5 oz / 15 g concentrate (MCL 333.27955)	A daily flower habit still has a legal ceiling
Licensed CRA shops	Labels and tests beat a mystery bag when you are counting days
Metro Detroit shift work	Night plant, hospital, or trade hours can add days the jar didn't cause
Michigan winter light	Dark weeks can stack with migraine. Mark them in the log.

If you're curious to try flower for the night you already live, start at the shop. Smell the jar. Keep the abort pill conversation with the person who writes it. We can talk terps and size. The CGRP shot stays with the person who writes it.

Frequently Asked Questions #

Q: Can a daily cannabis microdose reduce how often migraines show up? #

Not as a proven protocol. Some clinic charts show fewer headache days with regular cannabis, but no trial has tested a tiny daily dose as prevention. Rhyne 2016 saw 10.4 to 4.6 headache days a month in 121 charts. That's a chart signal. We still don't have a microdose RCT. Treat a daily pinch as an experiment you log, not as a substitute for a real preventive.

Q: Is cannabis only useful for aborting a migraine that already started? #

Abort is where the evidence is cleaner. Prevention is still a maybe. The Schuster Headache 2026 trial (PMC12872409) showed vaporized 6% THC + 11% CBD beat placebo at two hours for pain relief (67.2% vs 46.6%). The same paper says it didn't study frequent long-term use.

Q: What did the Colorado medical-cannabis chart review actually prove? #

It proved that people who stayed in those charts logged fewer headache days. It didn't prove cannabis caused the drop. Rhyne et al. was a retrospective review, not a randomized trial. Most people used cannabis daily for prevention and inhaled to abort. The authors asked for prospective studies. That request still stands.

Q: What did the vaporized-flower migraine trial test? #

It tested abort, on up to four separate attacks, with four puffs of NIDA flower against placebo flower. Schuster 2026 enrolled 92 adults and treated 247 attacks (NCT04360044). THC+CBD won the two-hour endpoints. CBD-only didn't. The washout between attacks was at least a week. That's the opposite of a nightly microdose.

Q: Does daily cannabis cause rebound or medication-overuse headache? #

It's associated with medication-overuse headache in chronic migraine charts. That's not the same as ICHD naming cannabis like it names triptans. Zhang 2021 found overuse headache in 81% of current cannabis users versus 41% of non-users (adjusted odds ratio 6.3). If your month is already 15-plus headache days, talk to the clinician before adding a daily pinch.

Q: How many triptan days a month count as overuse? #

Ten or more triptan days a month for more than three months, on top of the 15-plus headache-day pattern. That's ICHD-3 triptan-overuse headache. Base medication-overuse headache is headache on 15 or more days a month with regular overuse of an acute medicine for more than three months. Count both. Don't hide the plant days.

Q: Is migraine a qualifying condition for a Michigan medical marijuana card? #

No. Migraine isn't named. Chronic pain is. See the CRA eligible-conditions page. A physician may still certify you if your case fits a named condition or the severe-and-chronic-pain symptom lane. Adults 21+ can buy adult-use without a card under MCL 333.27955.

Q: Should I drop my CGRP shot, topiramate, or triptan if I try a daily low dose? #

No. Do not drop a medicine because a farm blog mentioned flower. The American Headache Society 2024 statement treats CGRP-targeting therapies as a first-line prevention option. Cannabis isn't on that list. If you change a preventive or an abortive, that's a clinician conversation. Stack questions go in medication interactions.

Q: Is flower or an edible better for abort vs a daily routine? #

Inhale is the faster abort tool in the papers. Daily oral exposure is a theory, not a Divine Toke SKU. Rhyne saw inhaled forms used to abort, and more trouble with edible timing. Schuster used vaporized flower. We sell flower and 1g joints, not edibles. If you want a long edible lane, that's another licensed Michigan brand.

Q: How long should I track frequency before deciding the daily dose did anything? #

Two to three full months of migraine-day counts, not one good week. Clinics already use monthly migraine days. Log abort days too. Compare similar months (two day-shift stretches, not vacation versus overtime). The journaling guide is the notebook. If the number doesn't move, the daily pinch didn't earn a forever spot.

Q: Does CBD-only flower abort a migraine? #

Not in the only modern abort trial we have. In Schuster 2026, the 11% CBD arm didn't beat placebo on two-hour pain relief, pain freedom, or most-bothersome-symptom freedom. The THC+CBD mix did. CBD-only as a daily preventive is a different, still-unproven question.

Q: What does Divine Toke sell if I want a small, repeatable amount? #

Sun-grown flower, 1g pre-rolls, and a 20-pack of those 1g joints. That's the catalog: no gummy, no half-gram listing. A 1g joint is a known size if you're trying to keep a day small. Start at the shop, ask for the COA, and don't treat the jar as a migraine milligram.

---

If you already live with the curtains, the abort question and the frequency question aren't the same night. Use the migraines pillar for the wider map. Use the microdosing guide if you are trying to stay functional. Use the journal if you are going to test a daily pinch anyway.

If you are curious to try Michigan sun-grown flower from a Detroit-rooted shop, we have jars, 1g joints, and the 20-pack. Smell first. Keep the neurologist in the loop.

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any new wellness routine.